Muralidhar Beeram

基本信息

Career Trajectory

Bio

Dr. Muralidhar Beeram is a board-certified medical oncologist and investigator practicing with the START Center in San Antonio, Texas. He was named in the list of America’s Top Oncologists in 2005, 2007, and 2008.

Dr. Beeram treats all solid tumors but has a special interest in the treatment of breast cancer, malignant melanoma, and in clinical trials of new anticancer agents. Dr. Beeram is the recipient of several peer-reviewed grant awards, including the prestigious American Society of Clinical Oncology Young Investigator Award and the American Federation for Aging Research Junior Investigator Award for his research.

Research Interests

Papers共 183 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Capivasertib Plus Cyclindependent Kinase 4/6 Inhibitor and Fulvestrant in Hormone Receptorpositive/human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Updated Phase 1b Analysis from CAPItello292

Erika Hamilton,Patrick Neven,Barbara Pistilli,Muralidhar Beeram,Virginia Borges,Mario Campone, Jose Luiz Miranda Guimaraes,Theodoros Foukakis,Annette Raskov Kodahl,Peter Lau,Elgene Lim,Iwona Lugowska, Greg Rychlik,Christopher Gresty,Claire Miller,Roberto Sommavilla,Dhivya Sudhan,Hope Rugo

CANCER RESEARCHno. 9 (2024)

Cited0Views0Bibtex

Abstract PO1-26-02: Enfortumab Vedotin (EV): Correlation of Estrogen Receptor Status and Nectin-4 Expression with Single Agent Efficacy in Breast XPDX Models

Crystal Moreno,Johnnie Flores,Alyssa Simonson, Maci DeBoer,Natalia Banos, Armando Diaz III, Morgan Lynch,Jim Lund, Leonora Leykum, Tahmi Rouzbahan,Manuel Pedregal,Kyriakos P. Papadopoulos,Amy Lang,Arthur Rosenthal,Drew Rasco,Gladys Rodriguez,Luis Rodriguez,Nehal Lakhani,Muralidhar Beeram,Amita Patnaik,Maria De Miguel,Ronald Drengler,Steven Abbate,Bernard Doger de Speville Uribe,Michael Wick

Cancer Researchno. 9_Supplement (2024): PO1-26

Cited0Views0Bibtex

Abstract PO1-26-03: Activity of Alpelisib in a Panel of Breast XPDX Models Harboring Hotspot and Uncommon PIK3CA Mutations

Mercedes Castaneda,Alyssa Simonson,Johnnie Flores, Maci DeBoer,Jim Lund, Tahmi Rouzbahan,Kyriakos P. Papadopoulos,Amy Lang,Gladys Rodriguez,Maryam Elmi,Arthur Rosenthal,Drew Rasco,Victor Moreno,Amita Patnaik,Tatiana Hernandez,Emiliano Calvo,Lon Smith,Manish Sharma,Muralidhar Beeram,Michael Wick

Cancer Researchno. 9_Supplement (2024): PO1-26

Cited0Views0Bibtex

Activity of Alpelisib in a Panel of Breast XPDX Models Harboring Hotspot and Uncommon PIK3CA Mutations

CANCER RESEARCHno. 9 (2024)

Cited0Views0Bibtex

Imlunestrant, an Oral Selective Estrogen Receptor Degrader, As Monotherapy and in Combination with Targeted Therapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Phase Ia/Ib EMBER Study

JOURNAL OF CLINICAL ONCOLOGYno. 35 (2024)

Cited0Views0WOSBibtex

Abstract LBO1-04: Primary Results from a Phase 2a Study of Zanidatamab (zani) + Palbociclib (palbo) + Fulvestrant (fulv) in HER2+/HR+ Metastatic Breast Cancer (Mbc)

Santiago Escrivá-de-Romani,Juan Miguel Cejalvo,Emilio Alba, Jennifer Friedmann,Álvaro Rodríguez Lescure,Marie-France Savard,Rossanna C. Pezo,Maria Gion,Manuel Ruíz - Borrego,Erika Hamilton,Timothy Pluard,Marc Webster,Muralidhar Beeram,Hannah Linden,Cristina Saura, Diana Shpektor, Bob Salim,Phoebe Harvey,Sara Hurvitz

Cancer Researchno. 9_Supplement (2024): LBO1-04

Cited0Views0Bibtex

Abstract PS12-09: Capivasertib Plus Cyclin-Dependent Kinase 4/6 Inhibitor and Fulvestrant in Hormone Receptor-Positive/human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Updated Phase 1b Analysis from CAPItello-292

Erika Hamilton,Patrick Neven,Barbara Pistilli,Muralidhar Beeram,Virginia Borges,Mario Campone, José Luiz Miranda Guimarães,Theodoros Foukakis,Annette Raskov Kodahl,Peter Lau,Elgene Lim,Iwona Ługowska, Greg Rychlik,Christopher Gresty,Claire Miller,Roberto Sommavilla,Dhivya Sudhan,Hope Rugo

Cancer Researchno. 9_Supplement (2024): PS12-09

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn

Medical Oncologist

Papers共 183 篇Author StatisticsCo-AuthorSimilar Experts